vs
Side-by-side financial comparison of Kenvue (KVUE) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.
Kenvue is the larger business by last-quarter revenue ($3.8B vs $2.5B, roughly 1.5× Tapestry, Inc.). Tapestry, Inc. runs the higher net margin — 22.4% vs 8.7%, a 13.7% gap on every dollar of revenue. On growth, Tapestry, Inc. posted the faster year-over-year revenue change (14.0% vs 3.2%). Tapestry, Inc. produced more free cash flow last quarter ($1.0B vs $744.0M). Over the past eight quarters, Tapestry, Inc.'s revenue compounded faster (29.9% CAGR vs -1.5%).
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.
KVUE vs TPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.8B | $2.5B |
| Net Profit | $330.0M | $561.3M |
| Gross Margin | 56.5% | 75.5% |
| Operating Margin | 14.2% | 28.6% |
| Net Margin | 8.7% | 22.4% |
| Revenue YoY | 3.2% | 14.0% |
| Net Profit YoY | 12.6% | 80.8% |
| EPS (diluted) | $0.16 | $2.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.8B | $2.5B | ||
| Q3 25 | $3.8B | $1.7B | ||
| Q2 25 | $3.8B | $1.7B | ||
| Q1 25 | $3.7B | $1.6B | ||
| Q4 24 | $3.7B | $2.2B | ||
| Q3 24 | $3.9B | $1.5B | ||
| Q2 24 | $4.0B | $1.6B | ||
| Q1 24 | $3.9B | $1.5B |
| Q4 25 | $330.0M | $561.3M | ||
| Q3 25 | $398.0M | $274.8M | ||
| Q2 25 | $420.0M | $-517.1M | ||
| Q1 25 | $322.0M | $203.3M | ||
| Q4 24 | $293.0M | $310.4M | ||
| Q3 24 | $383.0M | $186.6M | ||
| Q2 24 | $58.0M | $159.3M | ||
| Q1 24 | $296.0M | $139.4M |
| Q4 25 | 56.5% | 75.5% | ||
| Q3 25 | 59.1% | 76.3% | ||
| Q2 25 | 58.9% | 76.3% | ||
| Q1 25 | 58.0% | 76.1% | ||
| Q4 24 | 56.5% | 74.4% | ||
| Q3 24 | 58.5% | 75.3% | ||
| Q2 24 | 59.1% | 74.9% | ||
| Q1 24 | 57.6% | 74.7% |
| Q4 25 | 14.2% | 28.6% | ||
| Q3 25 | 16.7% | 19.3% | ||
| Q2 25 | 18.0% | -33.9% | ||
| Q1 25 | 14.9% | 16.0% | ||
| Q4 24 | 13.2% | 22.4% | ||
| Q3 24 | 16.8% | 16.7% | ||
| Q2 24 | 3.9% | 14.8% | ||
| Q1 24 | 14.1% | 13.8% |
| Q4 25 | 8.7% | 22.4% | ||
| Q3 25 | 10.6% | 16.1% | ||
| Q2 25 | 10.9% | -30.0% | ||
| Q1 25 | 8.6% | 12.8% | ||
| Q4 24 | 8.0% | 14.1% | ||
| Q3 24 | 9.8% | 12.4% | ||
| Q2 24 | 1.5% | 10.0% | ||
| Q1 24 | 7.6% | 9.4% |
| Q4 25 | $0.16 | $2.68 | ||
| Q3 25 | $0.21 | $1.28 | ||
| Q2 25 | $0.22 | $-2.30 | ||
| Q1 25 | $0.17 | $0.95 | ||
| Q4 24 | $0.16 | $1.38 | ||
| Q3 24 | $0.20 | $0.79 | ||
| Q2 24 | $0.03 | $0.67 | ||
| Q1 24 | $0.15 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $1.1B |
| Total DebtLower is stronger | — | $2.4B |
| Stockholders' EquityBook value | $10.8B | $551.2M |
| Total Assets | $27.1B | $6.5B |
| Debt / EquityLower = less leverage | — | 4.32× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $743.2M | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.1B | $7.3B | ||
| Q2 24 | $1.0B | $7.2B | ||
| Q1 24 | $1.2B | $7.4B |
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $7.0B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $7.7B |
| Q4 25 | $10.8B | $551.2M | ||
| Q3 25 | $10.6B | $399.5M | ||
| Q2 25 | $10.7B | $857.8M | ||
| Q1 25 | $10.1B | $1.5B | ||
| Q4 24 | $9.7B | $1.3B | ||
| Q3 24 | $10.6B | $3.0B | ||
| Q2 24 | $10.2B | $2.9B | ||
| Q1 24 | $10.6B | $2.8B |
| Q4 25 | $27.1B | $6.5B | ||
| Q3 25 | $27.2B | $6.4B | ||
| Q2 25 | $27.1B | $6.6B | ||
| Q1 25 | $26.3B | $7.3B | ||
| Q4 24 | $25.6B | $7.3B | ||
| Q3 24 | $26.9B | $13.7B | ||
| Q2 24 | $26.4B | $13.4B | ||
| Q1 24 | $27.3B | $13.7B |
| Q4 25 | — | 4.32× | ||
| Q3 25 | — | 5.95× | ||
| Q2 25 | — | 2.77× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 2.35× | ||
| Q2 24 | — | 2.39× | ||
| Q1 24 | — | 2.77× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $854.0M | $1.1B |
| Free Cash FlowOCF − Capex | $744.0M | $1.0B |
| FCF MarginFCF / Revenue | 19.7% | 41.5% |
| Capex IntensityCapex / Revenue | 2.9% | 1.7% |
| Cash ConversionOCF / Net Profit | 2.59× | 1.93× |
| TTM Free Cash FlowTrailing 4 quarters | $1.7B | $1.6B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $854.0M | $1.1B | ||
| Q3 25 | $294.0M | $112.6M | ||
| Q2 25 | $621.0M | $446.8M | ||
| Q1 25 | $428.0M | $144.3M | ||
| Q4 24 | $793.0M | $506.0M | ||
| Q3 24 | $249.0M | $119.5M | ||
| Q2 24 | $440.0M | $256.0M | ||
| Q1 24 | $287.0M | $97.8M |
| Q4 25 | $744.0M | $1.0B | ||
| Q3 25 | $196.0M | $80.2M | ||
| Q2 25 | $533.0M | $411.5M | ||
| Q1 25 | $249.0M | $113.4M | ||
| Q4 24 | $661.0M | $475.1M | ||
| Q3 24 | $190.0M | $93.9M | ||
| Q2 24 | $350.0M | $209.8M | ||
| Q1 24 | $134.0M | $78.8M |
| Q4 25 | 19.7% | 41.5% | ||
| Q3 25 | 5.2% | 4.7% | ||
| Q2 25 | 13.9% | 23.9% | ||
| Q1 25 | 6.7% | 7.2% | ||
| Q4 24 | 18.1% | 21.6% | ||
| Q3 24 | 4.9% | 6.2% | ||
| Q2 24 | 8.8% | 13.2% | ||
| Q1 24 | 3.4% | 5.3% |
| Q4 25 | 2.9% | 1.7% | ||
| Q3 25 | 2.6% | 1.9% | ||
| Q2 25 | 2.3% | 2.0% | ||
| Q1 25 | 4.8% | 2.0% | ||
| Q4 24 | 3.6% | 1.4% | ||
| Q3 24 | 1.5% | 1.7% | ||
| Q2 24 | 2.3% | 2.9% | ||
| Q1 24 | 3.9% | 1.3% |
| Q4 25 | 2.59× | 1.93× | ||
| Q3 25 | 0.74× | 0.41× | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.33× | 0.71× | ||
| Q4 24 | 2.71× | 1.63× | ||
| Q3 24 | 0.65× | 0.64× | ||
| Q2 24 | 7.59× | 1.61× | ||
| Q1 24 | 0.97× | 0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KVUE
| Self Care | $1.6B | 42% |
| Essential Health | $1.1B | 30% |
| Skin Health And Beauty | $1.0B | 28% |
TPR
| Coach | $1.4B | 57% |
| Other | $787.0M | 31% |
| Kate Spade Company | $290.0M | 12% |
